Emily S. Lebow

1.3k total citations
33 papers, 586 citations indexed

About

Emily S. Lebow is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Emily S. Lebow has authored 33 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 7 papers in Genetics. Recurrent topics in Emily S. Lebow's work include Lung Cancer Treatments and Mutations (11 papers), Brain Metastases and Treatment (9 papers) and Lung Cancer Research Studies (9 papers). Emily S. Lebow is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Brain Metastases and Treatment (9 papers) and Lung Cancer Research Studies (9 papers). Emily S. Lebow collaborates with scholars based in United States, Germany and Canada. Emily S. Lebow's co-authors include Justin F. Gainor, Harper Hubbeling, Helen A. Shih, Kevin Oh, William A. Mehan, Alice T. Shaw, William L. Hwang, Beow Y. Yeap, Andrzej Niemierko and W. Marston Linehan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Emily S. Lebow

29 papers receiving 579 citations

Peers

Countries citing papers authored by Emily S. Lebow

Since Specialization

Citations

This map shows the geographic impact of Emily S. Lebow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily S. Lebow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily S. Lebow more than expected).

Fields of papers citing papers by Emily S. Lebow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily S. Lebow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily S. Lebow. The network helps show where Emily S. Lebow may publish in the future.

Co-authorship network of co-authors of Emily S. Lebow

This figure shows the co-authorship network connecting the top 25 collaborators of Emily S. Lebow. A scholar is included among the top collaborators of Emily S. Lebow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily S. Lebow. Emily S. Lebow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell-Free Circulating Tumor DNA for NonInvasive Molecular Profiling Among Patients Undergoing Definitive Chemoradiation for Locally Advanced Lung Cancer 2025 ·Advances in Radiation Oncology ·Emily S. Lebow, (unknown), (unknown), Zhigang Zhang, (unknown), Daphna Y. Gelblum, (unknown), Annemarie F. Shepherd, Puneeth Iyengar, Jacob Y. Shin, Andreas Rimner, Bob T. Li, James M. Isbell, Narek Shaverdian, Maria Thor, Daniel R. Gomez	0
2	Outcomes of Palliative Whole Posterior Fossa Radiotherapy for Adult Brain Metastases 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), Emily S. Lebow, Harper Hubbeling, James D. Kolker, S. Nagda, Goldie Kurtz, Michelle Alonso‐Basanta	0
3	Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Emily S. Lebow, Kelly Fitzgerald, Narek Shaverdian, Rupesh Kotecha, Daniel R. Gomez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Juliana Eng, Kenneth Ng, Afsheen N. Iqbal, (unknown), (unknown)	0
4	Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer 2023 ·Journal for ImmunoTherapy of Cancer ·Joao V. Alessi, Adam Price, Allison L. Richards, Biagio Ricciuti, Xinan Wang, Arielle Elkrief, Federica Pecci, Alessandro Di Federico, (unknown), Emily S. Lebow, Patricia Mae G. Santos, Maria Thor, Andreas Rimner, Adam J. Schoenfeld, Jamie E. Chaft, Bruce E. Johnson, Daniel R. Gomez, Mark M. Awad, Narek Shaverdian	5
5	Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases 2023 ·JAMA Oncology ·Emily S. Lebow, Luke Pike, Andrew D. Seidman, Nelson S. Moss, Kathryn Beal, Yao Yu	28
6	The Impact of Co-Alterations on Outcomes after Local Therapy for Patients with KRAS-Mutant Lung Adenocarcinoma Brain Metastases 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Bruno Gaëta, Henry Walch, (unknown), Lukáš Kratochvíl, (unknown), Yoshiya Yamada, Changyuan Yu, (unknown), Daniel R. Gomez, Brandon S. Imber, James M. Isbell, B.T. Li, Yonina R. Murciano‐Goroff, Kathryn C. Arbour, N. Schultz, Emily S. Lebow, (unknown)	2
7	Stereotactic body radiation therapy for sarcoma pulmonary metastases 2023 ·Radiotherapy and Oncology ·Emily S. Lebow, Stephanie Lobaugh, Zhigang Zhang, Mark A. Dickson, Evan Rosenbaum, Sandra P. D’Angelo, Benjamin A. Nacev, Annemarie F. Shepherd, Narek Shaverdian, Suzanne L. Wolden, Abraham J. Wu, Daphna Y. Gelblum, Charles B. Simone, Daniel R. Gomez, Kaled M. Alektiar, William D. Tap, Andreas Rimner	4
8	Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patients with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab 2023 ·JAMA Network Open ·Emily S. Lebow, Annemarie F. Shepherd, (unknown), Michael Offin, Daphna Y. Gelblum, Abraham J. Wu, Charles B. Simone, Adam J. Schoenfeld, David R. Jones, Andreas Rimner, Jamie E. Chaft, Nadeem Riaz, Daniel R. Gomez, Narek Shaverdian	13
9	Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC 2023 ·Nature Communications ·Joao V. Alessi, Biagio Ricciuti, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe Lamberti, Arielle Elkrief, Scott J. Rodig, Emily S. Lebow, (unknown), Maria Thor, Andreas Rimner, Adam J. Schoenfeld, Jamie E. Chaft, Bruce E. Johnson, Daniel R. Gomez, Mark M. Awad, Narek Shaverdian	18
10	Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib 2023 ·Lung Cancer ·(unknown), (unknown), Emily S. Lebow, Jessica Flynn, Zhigang Zhang, Henry Walch, Harper Hubbeling, Kathryn Beal, Nelson S. Moss, Kenny Kwok Hei Yu, (unknown), Daniel W. Kelly, Daniel R. Gomez, Bob T. Li, Andreas Rimner, Nikolaus Schultz, Alexander Drilon, Brandon S. Imber, Luke Pike	5
11	Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer 2022 ·Translational Lung Cancer Research ·J. Haseltine, Michael Offin, Jessica Flynn, Zhigang Zhang, Emily S. Lebow, Khaled Aziz, Alex Makhnin, (unknown), Lee P. Lim, Mark Li, James M. Isbell, Daniel R. Gomez, Bob T. Li, Andreas Rimner	4
12	Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline 2022 ·Practical Radiation Oncology ·Lia M. Halasz, Albert Attia, Lisa Bradfield, Daniel J. Brat, John P. Kirkpatrick, Nadia N. Laack, Nafisha Lalani, Emily S. Lebow, Arthur K. Liu, Heather M. Niemeier, Joshua D. Palmer, Katherine B. Peters, Jason Sheehan, Reena Thomas, Sujay A. Vora, Daniel Wahl, Stephanie E. Weiss, D.N. Yeboa, Jim Zhong, Helen A. Shih	23
13	Modelling of late side-effects following cranial proton beam therapy 2021 ·Radiotherapy and Oncology ·(unknown), Armin Lühr, Linda Agolli, Rebecca Bütof, Chiara Valentini, Esther G.C. Troost, Michaël Baumann, (unknown), Dirk Geismar, Nayan Lamba, Emily S. Lebow, (unknown), J. Daly, Marc R. Bussière, Mechthild Krause, Beate Timmermann, Helen A. Shih, Steffen Löck	9
14	Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases 2020 ·Journal of Neuro-Oncology ·Emily S. Lebow, William L. Hwang, (unknown), Yi Wang, Andrzej Niemierko, William A. Mehan, Kevin Oh, Melin J. Khandekar, Henning Willers, Helen A. Shih	9
15	Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model 2019 ·Radiotherapy and Oncology ·Maximilian Niyazi, Andrzej Niemierko, Harald Paganetti, Matthias Söhn, Emily S. Lebow, Saveli Goldberg, Judith Adams, (unknown), Kevin Oh, William L. Hwang, Hsiao‐Ming Lu, Claus Belka, Paul M. Busse, Jay S. Loeffler, Helen A. Shih	27
16	Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non–Small Cell Lung Cancer 2018 ·Journal of Thoracic Oncology ·Harper Hubbeling, Emily S. Lebow, Nora Horick, (unknown), W. Marston Linehan, Kevin Oh, Alice T. Shaw, William A. Mehan, Helen A. Shih, Justin F. Gainor	95
17	Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Emily S. Lebow, Harper Hubbeling, Beow Y. Yeap, William A. Mehan, Alice T. Shaw, Kevin Oh, Justin F. Gainor, Helen A. Shih	104
18	The role of proton beam therapy in central neurocytoma: A single-institution experience 2018 ·Practical Radiation Oncology ·(unknown), Emily S. Lebow, Andrzej Niemierko, María Martínez-Lage, Marc R. Bussière, Torunn I. Yock, Jay S. Loeffler, William E. Butler, Bob S. Carter, Helen A. Shih	1
19	Keeping it in the family: the impact of marital status and next of kin on cancer treatment and survival 2016 ·The American Journal of Surgery ·Mariam F. Eskander, Emily S. Lebow, Lindsay A. Bliss, (unknown), (unknown), Sing Chau Ng, Jennifer F. Tseng	20
20	IQGAP1 and IQGAP3 Serve Individually Essential Roles in Normal Epidermal Homeostasis and Tumor Progression 2015 ·Journal of Investigative Dermatology ·(unknown), Andrew S. McNeal, Elizabeth K. Duperret, Seung Ja Oh, Emily S. Lebow, Todd W. Ridky	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact